Real life safety and effectiveness of nivolumab in older patients with non-small cell lung cancer: Results from the Belgian compassionate use program.

Sofie Joris,Thierry Pieters, Anne Sibille,Fréderique Bustin, Laurence Jacqmin, Hassan Rezaei Kalantari,Veerle Surmont,Jean-Charles Goeminne, Frederic Clinckart,Karin Pat,Wim Demey,Koen Deschepper,Marc Lambrechts,Stephane Holbrechts,Denis Schallier,Lore Decoster

Journal of Geriatric Oncology（2020）

引用 9|浏览13

暂无评分

摘要

This real life retrospective study confirms that safety and effectiveness of nivolumab is similar between different age groups, but that effectiveness is driven by performance status.

查看译文

关键词

Older,Performance status,Non-small cell lung cancer,Nivolumab

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要